Kind Biotechnology
PrivateCompany Overview
Kind Biotechnology is a biotechnology company developing an integrated organ network platform to support the ethical and scalable production of xenotransplant organs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
xenotransplantationorgan engineeringbiotechnologygenomic engineeringtransplant medicinelab-grown organsIntegrated Organ NetworkIONartificial genomic constructsCRISPRorgan shortagebio-printingregenerative medicinesynthetic biologybiotech R&D
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kind Biotechnology Comparables
Compare Kind Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| R3 Bio | 84% | |
| eGenesis | 79% | |
| Trestle Biotherapeutics | 78% | |
Kind Biotechnology Funding Rounds
Historical fundraising activity
Kind Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kind Biotechnology's valuation, stock price, and market status.
See something wrong or outdated?